Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery

J Am Coll Cardiol. 2001 Nov 1;38(5):1369-74. doi: 10.1016/s0735-1097(01)01561-3.

Abstract

Objectives: The goal of this study was to evaluate the effect of preconditioning on out-of-hospital ventricular fibrillation (VF) in patients with acute myocardial infarction (AMI).

Background: More than half of the deaths associated with AMI occur out of the hospital and within 1 h of symptom onset. In humans, preinfarction angina (PA), which can serve as a surrogate marker for preconditioning, reduces infarct size, but the protective effect against out-of-hospital VF has not been investigated.

Methods: Preinfarction angina status and acute coronary angiographic findings of 72 consecutive patients with AMI complicated by out-of-hospital VF were compared with 144 matched controls without this complication.

Results: Preinfarction angina is associated with a lower risk for VF (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.18 to 0.88). In patients with acute occlusion of the left coronary artery (LCA) (n = 136), the risk reduction is pronounced (OR: 0.25, 95% CI: 0.10 to 0.66), whereas, in patients with acute occlusion of the right coronary artery (RCA) (n = 67), the protective effect of PA on VF was not observed (OR: 2.25, 95% CI: 0.45 to 11.22). Subgroup and multivariate analyses show that the protective effect is independent of cardiovascular risk factors, preinfarction treatment with beta-adrenergic blocking agents or aspirin, the presence of collaterals or residual antegrade flow or the extent of coronary artery disease.

Conclusions: Preinfarction angina protects against out-of-hospital VF in patients with acute occlusion of the LCA. This protection is independent of risk factors or coronary anatomy. A larger study is needed to examine the apparently different effect in patients with acute occlusion of the RCA.

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Analysis of Variance
  • Angina Pectoris / complications*
  • Angina Pectoris / drug therapy
  • Angina Pectoris / physiopathology
  • Aspirin / therapeutic use
  • Case-Control Studies
  • Collateral Circulation
  • Coronary Angiography
  • Coronary Circulation
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / etiology*
  • Coronary Disease / mortality
  • Coronary Disease / therapy
  • Female
  • Hospitals, University
  • Humans
  • Ischemic Preconditioning, Myocardial*
  • Logistic Models
  • Male
  • Middle Aged
  • Myocardial Infarction / diagnostic imaging
  • Myocardial Infarction / etiology*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy
  • Netherlands / epidemiology
  • Patient Discharge
  • Risk Factors
  • Severity of Illness Index
  • Survival Analysis
  • Time Factors
  • Ventricular Fibrillation / diagnostic imaging*
  • Ventricular Fibrillation / etiology*
  • Ventricular Fibrillation / mortality

Substances

  • Adrenergic beta-Antagonists
  • Aspirin